Showing 40,201 - 40,220 results of 103,630 for search '(( 5 ((((nn decrease) OR (we decrease))) OR (a decrease)) ) OR ( e point decrease ))', query time: 1.26s Refine Results
  1. 40201
  2. 40202

    <i>miR-146a</i> LNA treatment inhibits OSCC oncogenicity. by Pei-Shi Hung (489732)

    Published 2013
    “…(C) <i>miR-146a</i> LNA treatment decreases the growth of SAS cells (Lt) and OECM-1 cells (Rt) with or without exogenous <i>miR-146a</i> expression. …”
  3. 40203

    Data_Sheet_1_Liraglutide Activates mTORC1 Signaling and AMPA Receptors in Rat Hippocampal Neurons Under Toxic Conditions.docx by Sung Woo Park (125584)

    Published 2018
    “…<p>The aim of the present study was to determine whether treatment with liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, would alter mammalian target of rapamycin complex 1 (mTORC1) signaling and/or α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor activity under dexamethasone-induced toxic conditions. …”
  4. 40204

    List of genes whose overexpression affects strain occupancy in a multi-strain biofilm. by Vitor Cabral (132275)

    Published 2014
    “…1<p>Fold Change in strain occupancy between Dox-treated and -untreated biofilm as deduced from GeneSpring GX 11 analysis; all strains showed p≤0.05. The fold-change with a higher value among 2 replicate probes is shown (<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1004542#ppat.1004542.s013" target="_blank">S3 Table</a>, sheet named “GeneSpring analysis-hits p<0.05”).…”
  5. 40205

    <i>Salmonella</i> A1-R targeting and efficacy on the melanoma PDOX model. by Mako Yamamoto (577524)

    Published 2016
    “…Tumor size of the <i>Salmonella</i> A1-R-treated group was significantly decreased compared with the untreated control group. …”
  6. 40206
  7. 40207
  8. 40208
  9. 40209
  10. 40210
  11. 40211
  12. 40212
  13. 40213
  14. 40214
  15. 40215
  16. 40216
  17. 40217

    Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis by Melinda S. Schuurman (6742886)

    Published 2019
    “…Fewer patients were treated with chemotherapy (4.4% in 1993–1998 <i>versus</i> 0.7% in 2011–2016). During a median follow-up time of 8 years, 0.9% developed a subsequent invasive ovarian carcinoma.…”
  18. 40218
  19. 40219

    Pulmonary function tests – an easy selection method for respiratory-gated radiotherapy in patients with left-sided breast cancer by Mari H. B. Hjelstuen (3642640)

    Published 2017
    “…</b> Dose to the heart (V25Gy and D<sub>mean</sub>) decreased with increasing TLV-CT. …”
  20. 40220